ResMed, a health technology company focused on sleep, breathing, and care delivered in the home, launched AirSenseTM 11 in India, the company’s next-generation Continuous Positive Airway Pressure (CPAP) device designed to make it easier for individuals with Obstructive Sleep Apnea (OSA) to start and stay on therapy, according to a press release from ResMed.
According to the ResMed 2024 Global Sleep Survey, which was carried out in 17 markets across the globe, a startling 46% of participants had a history of OSA. Nevertheless, 33% of these respondents either decided not to seek treatment or began using self-help techniques to address their sleep issues. About 936 million people worldwide suffer from OSA, the most prevalent sleep-related breathing disorder, which is characterized by snoring and happens when the throat muscles relax and block the airway.
In response to the growing number of sleep apnea cases in India, ResMed unveiled the AirSenseTM 11, which has new features like Care Check-In and Personal Therapy Assistant that are intended to give PAP users personalized advice and make therapy and nightly use more comfortable. Remote software updates are another feature that allows users to enjoy the most recent version of these tools every night, the release added.
Sandeep Gulati, General Manager, ResMed, India, South Asia said, “AirSenseTM 11’s new tailored features along with our myAir patient engagement app help give people the support they need to use CPAP – the gold standard for treating sleep apnea – comfortably and confidently every night. The importance of quality sleep cannot be overstated – and yet it is hard to achieve. The AirSenseTM 11, with its full suite of digital health features to make it easier for people to not only start, but stay on CPAP therapy, helping people who suffer from sleep apnea breathe better, sleep better and live better lives.
The AirSenseTM 11 includes access to myAir (ResMed’s patient engagement app) and AirView (ResMed’s remote monitoring platform for clinicians), which help bring overall patient adherence as high as 87%. The myAir app tracks the time patients spend using CPAP therapy, the number of sleep apnea events per hour, mask leaks, and the number of times a mask was removed, providing nightly data on breathing, coaching tips, and support directly to their phone.
AirView provides a secure, cloud-based patient management system for online patient monitoring that enables healthcare professionals to access patient data quickly, share clinical insights with other health professionals, improve care and reduce costs related to patient follow-up, the release added.
